Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4): A 26-week double-blind study
Keyword(s):
2016 ◽
Vol 18
(12)
◽
pp. 1207-1216
◽
2018 ◽
Vol 22
(1)
◽
pp. 41
◽
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 15
(3)
◽
pp. 234-240
◽
2011 ◽
Vol 13
(5)
◽
pp. 418-425
◽
Keyword(s):
2012 ◽
Vol 14
(4)
◽
pp. 348-357
◽
Keyword(s):